Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
Alberto Aimo(Scuola Superiore Sant'Anna), Claudio Rapezzi(University of Ferrara), Gianfranco Sinagra(Società Italiana di Cardiologia), Georgios Georgiopoulos(St Thomas' Hospital), Giuseppe Vergaro(Scuola Superiore Sant'Anna), Marco Merlo(Universidade da Coruña), Linda Pagura(University of Trieste), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Michele Emdin(Scuola Superiore Sant'Anna)
Cited by 197
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2010|485
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
|Journal of the American College of Cardiology|2016|472